NU Skin Enterprises Inc
NYSE:NUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NU Skin Enterprises Inc
NYSE:NUS
|
US |
|
Atul Ltd
NSE:ATUL
|
IN |
|
Abeo SA
PAR:ABEO
|
FR |
|
X4 Pharmaceuticals Inc
NASDAQ:XFOR
|
US |
|
Worley Ltd
ASX:WOR
|
AU |
|
M
|
Mercialys SA
PAR:MERY
|
FR |
|
V
|
Vanda Pharmaceuticals Inc
SWB:VM4
|
US |
|
B
|
Boeing Co
LSE:BOE
|
US |
|
N
|
NIO Inc
F:N3IA
|
CN |
|
Plant Health Care PLC
LSE:PHC
|
US |
|
E
|
Exelixis Inc
XETRA:EX9
|
US |
|
V
|
Vortex Energy Corp
OTC:VTECF
|
CA |
|
Aures Technologies SA
F:A5R
|
FR |
Wall St Price Targets
NUS Price Targets Summary
NU Skin Enterprises Inc
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NUS's stock price target?
Not Available
NUS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for NU Skin Enterprises Inc?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for NU Skin Enterprises Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Operating Income has been -7%. The projected CAGR for the next 2 years is 5%.
What is the Net Income forecast for NU Skin Enterprises Inc?
Projected CAGR
-36%
Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is -36%.
